QSS
AKRO

Quantitative Systematic Strategies’s Akero Therapeutics AKRO Stock Holding History

Quantitative Systematic Strategies’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,728
Closed -$340K – 455
2021
Q1 		$340K Buy
11,728
+84
+0.7% +$2.54K 0.05% 452
2020
Q4 		$300K Buy
11,644
+1,510
+15% +$42K 0.04% 485
2020
Q3 		$312K Buy
+10,134
New +$354K 0.05% 431

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Quantitative Systematic Strategies's AKRO Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Akero Therapeutics (AKRO) in Q2 2021, closing a stake of 11,728 shares — an estimated $340K sold.

Quantitative Systematic Strategies first reported a position in AKRO in Q3 2020 and held it in 3 quarters. The position peaked at $340K in Q1 2021. 97 funds tracked by Wall St. Rank hold AKRO as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Akero Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,728 Akero Therapeutics shares in Q2 2021, an estimated $340K.
  • Quantitative Systematic Strategies first reported a position in Akero Therapeutics in Q3 2020 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Akero Therapeutics position peaked at $340K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.